Natixis Advisors LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 521,084 shares of the medical equipment provider's stock after purchasing an additional 1,082 shares during the period. Natixis Advisors LLC owned approximately 0.15% of Intuitive Surgical worth $258,077,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG boosted its holdings in shares of Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after buying an additional 883 shares in the last quarter. New Age Alpha Advisors LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $1,098,000. Level Four Advisory Services LLC grew its position in shares of Intuitive Surgical by 18.3% in the 4th quarter. Level Four Advisory Services LLC now owns 894 shares of the medical equipment provider's stock worth $467,000 after buying an additional 138 shares during the period. Finally, Everstar Asset Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $213,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently commented on ISRG shares. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Royal Bank Of Canada lifted their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a report on Wednesday, July 23rd. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. BTIG Research upped their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $592.05.
Check Out Our Latest Report on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,903 shares of company stock worth $7,932,778. Corporate insiders own 0.70% of the company's stock.
Intuitive Surgical Stock Performance
Shares of ISRG stock traded up $2.03 on Friday, reaching $483.12. The stock had a trading volume of 2,982,876 shares, compared to its average volume of 1,997,437. The company has a 50 day simple moving average of $524.01 and a 200 day simple moving average of $533.35. The stock has a market cap of $173.19 billion, a P/E ratio of 67.38, a price-to-earnings-growth ratio of 5.04 and a beta of 1.60. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.78 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.